smrd2023.efomp.orgSymposium on Molecular Radiotherapy Dosimetry: The future of

theragnostics theragnostics Toggle Navigation Home Organisation Sponsors Final Programme (updated) Abstract Submission Registration Venue (changed) Contact Us Symposium on Molecular Radiotherapy Dosimetry: The future of theragnostics November 9th -11th 2023, Athens, Greece Final Program Available Abstract Book Available The objective of the EFOMP Special Interest Group for Radionuclide Internal Dosimetry (SIG) is to establish a network of medical physicists working in radionuclide dosimetry. The SIG aims to fulfil the need for networking, education, research and professional exchanges in this field. To fulfil these aims, EFOMP SIG_FRID will organise a Symposium on molecular radiotherapy dosimetry in Athens, Greece. The Symposium will give the opportunity: to review and share ongoing developments in radionuclide imaging and dosimetry; to consider how personalised treatments may improve effectiveness at a time of rapid expansion of theragnostics and molecular radiotherapy to discuss networking and synergies within a muti-disciplinary community at a time of challenge and opportunity. Invited Speakers Irène Buvat Institut Curie, Orsay, France AI: a game changer in quantitative molecular imaging and clinical dosimetry Mark Gaze University College of London, UK Can dosimetry improve the outcome of molecular radiotherapy for neuroblastoma? Caroline Stokke Oslo University Hospital, Norway Implementation of Dosimetry for Radionuclide Therapy: Results from a European Survey Jan Taprogge Royal Marsden Hospital, Sutton, UK Quantitative imaging and dosimetry of radioiodine in multi-centre clinical trials Carlo Chiesa Istituto Nazionale Tumori, Milan, Italy Dosimetry and clinical outcome in radioembolization: light and shadow Manuel Bardiès Institut de Recherche en Cancérologie de Montpellier, France Implementing QA in clinical dosimetry Gerhard Glatting University of Ulm, Germany Time-Activity Data, Model Fitting and Model Selection in Molecular Radiotherapy Dosimetry Anna Sundlöv Swedish Medical Products Agency, Sweden Therapeutic radiopharmaceuticals in a changing regulatory landscape Marta Cremonesi European Institute of Oncology, Milano, Italy Dose-effects in Molecular Radiotherapy: lutetium-labelled radiopharmaceuticals Glenn Flux Royal Marsden Hospital, UK EFOMP policy statement on Dosimetry in Molecular Radiotherapy – The Final Countdown? Katarina Sjögreen-Gleisner Lund University, Sweden EFOMP policy statement on Dosimetry in Molecular Radiotherapy – The Final Countdown? Organised by Special Interest Group for Radionuclide Internal Dosimetry Hosted by This course has been accredited by EBAMP as a CPD event for Medical Physicists at EQF Level 7 The event has been judged to have 19 hours of educational experience, which, according to the EBAMP protocol is equivalent to 27 CPD points. The Accreditation Code for the event is: APP00249 Register to the symposium Submit your abstract Venue Hotel TITANIA 52 Panepistimiou Str., 10678, Athens Home Organisation Sponsors Final Programme (updated) Abstract Submission Registration Venue (changed) Contact Us Hestia | Developed...